Join Free

Research and publish the best content.

Hematology

12.8K views | +0 today

Tags

# B-cell acute lymphoblastic leukemia 2

# high throughput drug screen 1

# mixed lineage leukemia (MLL) 1

# sensitivity and resistance testing 1

#11th European Congress Hematologic Mali 1

#acute lymphoblastic leukemia 1

#acute lymphoblastic leukemia (ALL) 1

#acute lymphoblastic leukemia ALL 2

#acute lymphocytic leukemia (ALL) 1

#Acute Myelogenous Leukemia AML 1

#acute myeloid leukaemia AML 2

#acute myeloid leukemia 2

#acute myeloid leukemia (AML) 1

#adult T cell leukaemia/lymphoma 1

#ALL 1

#Amgen 1

#AML 1

#Amphivena Therapeutics 1

#anti CD20 mabs 1

#antibody drug conjugates 2

#ASH 1

#Aurora kinase A 1

#Aurora kinase B 1

#Aurora kinase C 1

#Aurora kinase inhibitors 1

#Aurora kinases 1

#B cell activating factor 1

#B cell ALL 2

#B cell leukemia 1

#B cell lymphoma 2

#B cell malignancies 1

#BAFF 1

#BioCentury 1

#biomarkers 1

#Bispecific T-cell engagers (BiTEs) 1

#BiTE® 1

#Blinatumomab 4

#BRCA1/BRCA2 mutations 1

#Breakthrough Therapy Designation 1

#Cancer Cell 1

#cancer immunotherapy 1

#cancer vaccines 1

#CAR 1

#CAR T cell immunotherapy 4

#CAR T cell therapy 2

#CAR-TCR 3

#CART19 1

#CD19 1

#CD33 CAR 1

#CellPress 1

#Chimeric antigen receptors (CARs) 2

#chronic lymphocytic leukemia 1

#chronic lymphocytic leukemia (CLL) 1

#chronic myeloid leukemia (CML) 1

#Chronic myeloid leukemia CML 2

#CLL 1

#CTL019 1

#cytotoxic T lymphocyte 1

#Dendritic cell vaccine 2

#Dendritic cells 2

#desatinib 1

#Engineered T cells 1

#ESMO 1

#FDA approval 1

#FDA priority review 1

#Hematological Cancers 1

#human T cell leukaemia virus type-I 1

#imatinib 1

#immuno-oncology 2

#Immunomedics 1

#immunotherapy 2

#induction therapy 1

#Inotuzumab ozogamicin 2

#JAMA 1

#JAMA Oncology 1

#leukemia 3

#Lymphoma 1

#MD Anderson Cancer Center 1

#Medigene AG 1

#milatuzumab 1

#MLL-rearranged leukemia 1

#Monoclonal antibodies (mAbs) 6

#multiple myeloma 4

#Nilotinib 1

#NK cells 1

#non-Hodgkin lymphoma NHL 1

#obinutuzumab 2

#ofatumumab 2

#Olaparib 1

#Oncodesign 1

#orphan drug 1

#overall response rate ORR 1

#Overall survival 1

#PARP 1 1

#PARP inhibitors 1

#pathogenesis MM 1

#PDUFA 1

#Ph -ve ALL 1

#Phase 1 1

#Phase I 1

#Philippe Genne 1

#Plasma cell myeloma 1

#PLoS One 1

#progression free survival 1

#REMS 1

#Rituximab 1

#second generation of AKI 1

#surrogate end point 1

#T cell activation 1

#targeted therapy 1

#therapeutic mabs 1

#tyrosine kinase inhibitors (TKIs) 1

#Youtube 1

acute lymphoblastic leukaemia 1

ALL 1

AML 1

anemia 1

cancer 1

cancer human treatment 1

CommuniquéDePresse2015 1

covid-19 4

Cytometry part B 1

Flow cytometry 1

Flow cytometry diagnosis 1

immune diagnosis 1

Immunoassay 1

infection 1

influenza 1

INSB 1

IPBS 1

leukaemia 1

Leukemia 1

myeloma 2

platelets 2

post-analytical 1

pre-analytical 1

Quality 1

sickle cell disease 48

Hematology

Diagnosis, Therapy, Follow-up

Curated by Gilbert C FAURE

Your new post is loading...

Rescooped by Gilbert C FAURE from from Flow Cytometry to Cytomics

Scoop.it!

Absolute lymphocyte counts refine minimal residual disease-based risk stratification in childhood acute lymphoblastic leukemia - Rabin - 2011 - Pediatric Blood & Cancer - Wiley Online Library | Hematology | Scoop.it

From onlinelibrary.wiley.com - July 26, 2012 3:35 PM

No comment yet.

Rescooped by Gilbert C FAURE from Immunology and Biotherapies

Scoop.it!

From clinicaltrials.gov - July 26, 2012 3:32 PM

No comment yet.

Rescooped by Gilbert C FAURE from Immunology and Biotherapies

Scoop.it!

From trialx.com - July 26, 2012 3:31 PM

No comment yet.

Rescooped by Gilbert C FAURE from Immunology and Biotherapies

Scoop.it!

From trialx.com - July 26, 2012 3:30 PM

No comment yet.

Rescooped by Gilbert C FAURE from from Flow Cytometry to Cytomics

Scoop.it!

From news.wustl.edu - July 26, 2012 3:35 PM

No comment yet.

Rescooped by Gilbert C FAURE from Immunology and Biotherapies

Scoop.it!

From clinicaltrials.gov - July 26, 2012 3:31 PM

No comment yet.

Rescooped by Gilbert C FAURE from Immunology and Biotherapies

Scoop.it!

From cancerkick.com - July 26, 2012 3:30 PM

No comment yet.

Hematology

Absolute lymphocyte counts refine minimal residual disease-based risk stratification in childhood acute lymphoblastic leukemia - Rabin - 2011 - Pediatric Blood & Cancer - Wiley Online Library

Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma - Full Text View - Clinica...

Biotest’s Antibody-drug Conjugate BT-062 In Multiple Myeloma Combination Therapy

Elotuzumab, CS1 Directed Antibody Therapy For Multiple Myeloma: Clinical Trial Results

Hundreds of random mutations in leukemia related to aging, not cancer | Newsroom | Washington University in St. Louis

Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia - Full Text View - ClinicalTrials.gov

Cytomedix Announces Collaboration With Duke University on Phase ...